[{"address1": "100 Columbia", "city": "Aliso Viejo", "state": "CA", "zip": "92656", "country": "United States", "phone": "949 521 7830", "website": "https://www.rxsight.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.", "fullTimeEmployees": 374, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ronald M. Kurtz M.D.", "age": 60, "title": "President, CEO & Director", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1207937, "exercisedValue": 0, "unexercisedValue": 8573785}, {"maxAge": 1, "name": "Mr. Eric J. Weinberg", "age": 62, "title": "Co-President & Chief Commercial Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 762739, "exercisedValue": 0, "unexercisedValue": 13419076}, {"maxAge": 1, "name": "Ms. Shelley B. Thunen", "age": 69, "title": "Co-President & Chief Financial Officer", "yearBorn": 1954, "fiscalYear": 2023, "totalPay": 762223, "exercisedValue": 0, "unexercisedValue": 5881998}, {"maxAge": 1, "name": "Dr. Ilya  Goldshleger Ph.D.", "age": 48, "title": "Co-President & Chief Operating Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 761458, "exercisedValue": 0, "unexercisedValue": 10092691}, {"maxAge": 1, "name": "Ms. Rebecca  Williston", "title": "Vice President of Accounting & Finance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Haller Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Oliver  Moravcevic", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Everly", "title": "Senior VP of Sales of North America", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roy  Freeman", "title": "Senior VP of Marketing & Professional Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Vaughn", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 49.57, "open": 50.07, "dayLow": 49.42, "dayHigh": 50.54, "regularMarketPreviousClose": 49.57, "regularMarketOpen": 50.07, "regularMarketDayLow": 49.42, "regularMarketDayHigh": 50.54, "beta": 1.192, "forwardPE": -95.05661, "volume": 227412, "regularMarketVolume": 227412, "averageVolume": 463640, "averageVolume10days": 266970, "averageDailyVolume10Day": 266970, "marketCap": 1999219456, "fiftyTwoWeekLow": 20.66, "fiftyTwoWeekHigh": 66.54, "priceToSalesTrailing12Months": 17.357801, "fiftyDayAverage": 51.8894, "twoHundredDayAverage": 52.648075, "currency": "USD", "enterpriseValue": 1777345664, "profitMargins": -0.31926, "floatShares": 34011338, "sharesOutstanding": 39682800, "sharesShort": 2193075, "sharesShortPriorMonth": 2298931, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0553, "heldPercentInsiders": 0.05154, "heldPercentInstitutions": 0.88149, "shortRatio": 5.15, "shortPercentOfFloat": 0.058000002, "impliedSharesOutstanding": 39682800, "bookValue": 6.947, "priceToBook": 7.2520514, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -36771000, "trailingEps": -0.99, "forwardEps": -0.53, "pegRatio": -0.81, "enterpriseToRevenue": 15.431, "enterpriseToEbitda": -46.397, "52WeekChange": 1.4093735, "SandP52WeekChange": 0.39389753, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "RXST", "underlyingSymbol": "RXST", "shortName": "RxSight, Inc.", "longName": "RxSight, Inc.", "firstTradeDateEpochUtc": 1627651800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "07da8956-a5ad-3592-ab35-e9dc0189ee49", "messageBoardId": "finmb_62603649", "gmtOffSetMilliseconds": -14400000, "currentPrice": 50.38, "targetHighPrice": 75.0, "targetLowPrice": 54.0, "targetMeanPrice": 64.86, "targetMedianPrice": 65.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 233284000, "totalCashPerShare": 5.879, "ebitda": -38307000, "totalDebt": 11410000, "quickRatio": 13.203, "currentRatio": 14.335, "totalRevenue": 115177000, "debtToEquity": 4.146, "revenuePerShare": 3.135, "returnOnAssets": -0.10576, "returnOnEquity": -0.17007999, "freeCashflow": -19181500, "operatingCashflow": -29619000, "revenueGrowth": 0.676, "grossMargins": 0.66263, "ebitdaMargins": -0.33258998, "operatingMargins": -0.23886, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-28"}]